|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1994-10-13
|
|
pubmed:abstractText |
New biologic prognostic factors are needed to guide the treatment of patients with colorectal cancer. The prognostic value of the altered expression of the cell surface glycoprotein gp78, which has been implicated in tumor-cell invasion and metastasis as an autocrine motility factor (AMF) receptor, was evaluated.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
74
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1855-62
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8082090-Adult,
pubmed-meshheading:8082090-Aged,
pubmed-meshheading:8082090-Aged, 80 and over,
pubmed-meshheading:8082090-Colorectal Neoplasms,
pubmed-meshheading:8082090-Female,
pubmed-meshheading:8082090-Humans,
pubmed-meshheading:8082090-Male,
pubmed-meshheading:8082090-Middle Aged,
pubmed-meshheading:8082090-Neoplasm Invasiveness,
pubmed-meshheading:8082090-Neoplasm Metastasis,
pubmed-meshheading:8082090-Neoplasm Proteins,
pubmed-meshheading:8082090-Neoplasm Recurrence, Local,
pubmed-meshheading:8082090-Neoplasm Staging,
pubmed-meshheading:8082090-Prognosis,
pubmed-meshheading:8082090-Receptors, Autocrine Motility Factor,
pubmed-meshheading:8082090-Receptors, Cytokine,
pubmed-meshheading:8082090-Retrospective Studies,
pubmed-meshheading:8082090-Tumor Markers, Biological,
pubmed-meshheading:8082090-Ubiquitin-Protein Ligases
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence.
|
|
pubmed:affiliation |
Department of Surgical Oncology, Center for Adult Diseases, Osaka, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
